Artwork

コンテンツは Joseph M. Casciani, PhD and Joseph M. Casciani によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Joseph M. Casciani, PhD and Joseph M. Casciani またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal
Player FM -ポッドキャストアプリ
Player FMアプリでオフラインにしPlayer FMう!

Prostate Cancer Awareness: What We Need to Know

41:22
 
シェア
 

Manage episode 436537624 series 2897475
コンテンツは Joseph M. Casciani, PhD and Joseph M. Casciani によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Joseph M. Casciani, PhD and Joseph M. Casciani またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal
This podcast takes a close look at the risk factors for prostate cancer, the second leading cause of cancer deaths in the U.S. Our guest is Paul Arangua, MPH in Epidemiology and an educator/researcher with the Prostate Conditions Education Council. We explore the incidence of prostate cancer, the risk factors, screening recommendations, and treatment outcomes. Why is prostate cancer so virulent? When left untreated, why does it spread so rapidly to other tissue and organs in the body? What is the survival rate when caught early? And, what is the relatively high mortality rate if left unidentified and localized in the body? Our guest shares PSA screening recommendations for different age groups, as well as newer screens using genomic markers. What lifestyle changes are closely aligned with prevention? This is a highly educational and must-know topic for all men, and partners. Be sure to tune in. Mini Bio Paul Arangua MPH is an accomplished public health professional, specializing in prostate cancer and men's health. With a strong background in clinical environments, Paul has navigated various aspects of prostate cancer, from screening to 3D diagnostics, innovative focal therapies and disease progression. His expertise spans over 17 years, working alongside Dr. E. David Crawford conducting research in clinical epidemiology, medical device proof-of-concept, FDA regulatory strategy, and health administration. Paul has played key roles in startups like Triopsy Medical, showcasing leadership in research, product development, and engineering design for cutting-edge technologies in prostate cancer diagnosis. Beyond his professional work, he actively engages in educational initiatives and patient advocacy. He serves as the Director of Research and Patient Insights at the Prostate Conditions Education Council. Paul has taken part in numerous speaking engagements, abstracts, and publications, highlighting his commitment to research and knowledge-sharing within the medical community. Covering topics from innovative biomarkers to novel diagnostic algorithms, his extensive skill set in data management, research, project management, and patient education underscores his dedication to advancing prostate cancer research and promoting men's health awareness. For Our Listeners Prostate Conditions Education Council
  continue reading

101 つのエピソード

Artwork
iconシェア
 
Manage episode 436537624 series 2897475
コンテンツは Joseph M. Casciani, PhD and Joseph M. Casciani によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Joseph M. Casciani, PhD and Joseph M. Casciani またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal
This podcast takes a close look at the risk factors for prostate cancer, the second leading cause of cancer deaths in the U.S. Our guest is Paul Arangua, MPH in Epidemiology and an educator/researcher with the Prostate Conditions Education Council. We explore the incidence of prostate cancer, the risk factors, screening recommendations, and treatment outcomes. Why is prostate cancer so virulent? When left untreated, why does it spread so rapidly to other tissue and organs in the body? What is the survival rate when caught early? And, what is the relatively high mortality rate if left unidentified and localized in the body? Our guest shares PSA screening recommendations for different age groups, as well as newer screens using genomic markers. What lifestyle changes are closely aligned with prevention? This is a highly educational and must-know topic for all men, and partners. Be sure to tune in. Mini Bio Paul Arangua MPH is an accomplished public health professional, specializing in prostate cancer and men's health. With a strong background in clinical environments, Paul has navigated various aspects of prostate cancer, from screening to 3D diagnostics, innovative focal therapies and disease progression. His expertise spans over 17 years, working alongside Dr. E. David Crawford conducting research in clinical epidemiology, medical device proof-of-concept, FDA regulatory strategy, and health administration. Paul has played key roles in startups like Triopsy Medical, showcasing leadership in research, product development, and engineering design for cutting-edge technologies in prostate cancer diagnosis. Beyond his professional work, he actively engages in educational initiatives and patient advocacy. He serves as the Director of Research and Patient Insights at the Prostate Conditions Education Council. Paul has taken part in numerous speaking engagements, abstracts, and publications, highlighting his commitment to research and knowledge-sharing within the medical community. Covering topics from innovative biomarkers to novel diagnostic algorithms, his extensive skill set in data management, research, project management, and patient education underscores his dedication to advancing prostate cancer research and promoting men's health awareness. For Our Listeners Prostate Conditions Education Council
  continue reading

101 つのエピソード

Усі епізоди

×
 
Loading …

プレーヤーFMへようこそ!

Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。

 

クイックリファレンスガイド